Literature DB >> 31185208

Precision Oncology: Three Small Steps Forward.

Hannah C Wise1, David B Solit2.   

Abstract

Only a subset of cancer patients currently benefit from personalized treatment approaches. Detection of actionable drug targets in cell-free DNA, more comprehensive molecular profiling integrating transcriptional analyses, and personalized combination regimens all hold promise in expanding the benefits of personalized oncology to larger numbers of cancer patients.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2019        PMID： 31185208      PMCID： PMC7398581          DOI： 10.1016/j.ccell.2019.05.009

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  8 in total

1.  Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.

Authors:  Daniel D Von Hoff; Joseph J Stephenson; Peter Rosen; David M Loesch; Mitesh J Borad; Stephen Anthony; Gayle Jameson; Susan Brown; Nina Cantafio; Donald A Richards; Tom R Fitch; Ernesto Wasserman; Cristian Fernandez; Sylvan Green; William Sutherland; Michael Bittner; Arlet Alarcon; David Mallery; Robert Penny
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

2.  Translational medicine: Primed for resistance.

Authors:  David B Solit; Pasi A Jänne
Journal:  Nature       Date:  2012-02-29       Impact factor: 49.962

3.  Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study.

Authors:  Dominic G Rothwell; Mahmood Ayub; Natalie Cook; Fiona Thistlethwaite; Louise Carter; Emma Dean; Nigel Smith; Shaun Villa; Joanne Dransfield; Alexandra Clipson; Daniel White; Kamrun Nessa; Saba Ferdous; Matthew Howell; Avinash Gupta; Bedirhan Kilerci; Sumitra Mohan; Kris Frese; Sakshi Gulati; Crispin Miller; Allan Jordan; Helen Eaton; Nicholas Hickson; Ciara O'Brien; Donna Graham; Claire Kelly; Sreeja Aruketty; Robert Metcalf; Jaseela Chiramel; Nadina Tinsley; Alexander J Vickers; Roopa Kurup; Hannah Frost; Julie Stevenson; Siobhan Southam; Dónal Landers; Andrew Wallace; Richard Marais; Andrew M Hughes; Ged Brady; Caroline Dive; Matthew G Krebs
Journal:  Nat Med       Date:  2019-04-22       Impact factor: 53.440

4.  Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.

Authors:  Jordi Rodon; Jean-Charles Soria; Raanan Berger; Wilson H Miller; Eitan Rubin; Aleksandra Kugel; Apostolia Tsimberidou; Pierre Saintigny; Aliza Ackerstein; Irene Braña; Yohann Loriot; Mohammad Afshar; Vincent Miller; Fanny Wunder; Catherine Bresson; Jean-François Martini; Jacques Raynaud; John Mendelsohn; Gerald Batist; Amir Onn; Josep Tabernero; Richard L Schilsky; Vladimir Lazar; J Jack Lee; Razelle Kurzrock
Journal:  Nat Med       Date:  2019-04-22       Impact factor: 53.440

5.  PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR.

Authors:  Martin L Sos; Mirjam Koker; Barbara A Weir; Stefanie Heynck; Rosalia Rabinovsky; Thomas Zander; Jens M Seeger; Jonathan Weiss; Florian Fischer; Peter Frommolt; Kathrin Michel; Martin Peifer; Craig Mermel; Luc Girard; Michael Peyton; Adi F Gazdar; John D Minna; Levi A Garraway; Hamid Kashkar; William Pao; Matthew Meyerson; Roman K Thomas
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

6.  OncoKB: A Precision Oncology Knowledge Base.

Authors:  Debyani Chakravarty; Jianjiong Gao; Sarah M Phillips; Ritika Kundra; Hongxin Zhang; Jiaojiao Wang; Julia E Rudolph; Rona Yaeger; Tara Soumerai; Moriah H Nissan; Matthew T Chang; Sarat Chandarlapaty; Tiffany A Traina; Paul K Paik; Alan L Ho; Feras M Hantash; Andrew Grupe; Shrujal S Baxi; Margaret K Callahan; Alexandra Snyder; Ping Chi; Daniel Danila; Mrinal Gounder; James J Harding; Matthew D Hellmann; Gopa Iyer; Yelena Janjigian; Thomas Kaley; Douglas A Levine; Maeve Lowery; Antonio Omuro; Michael A Postow; Dana Rathkopf; Alexander N Shoushtari; Neerav Shukla; Martin Voss; Ederlinda Paraiso; Ahmet Zehir; Michael F Berger; Barry S Taylor; Leonard B Saltz; Gregory J Riely; Marc Ladanyi; David M Hyman; José Baselga; Paul Sabbatini; David B Solit; Nikolaus Schultz
Journal:  JCO Precis Oncol       Date:  2017-05-16

7.  Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Authors:  Ahmet Zehir; Ryma Benayed; Ronak H Shah; Aijazuddin Syed; Sumit Middha; Hyunjae R Kim; Preethi Srinivasan; Jianjiong Gao; Debyani Chakravarty; Sean M Devlin; Matthew D Hellmann; David A Barron; Alison M Schram; Meera Hameed; Snjezana Dogan; Dara S Ross; Jaclyn F Hechtman; Deborah F DeLair; JinJuan Yao; Diana L Mandelker; Donavan T Cheng; Raghu Chandramohan; Abhinita S Mohanty; Ryan N Ptashkin; Gowtham Jayakumaran; Meera Prasad; Mustafa H Syed; Anoop Balakrishnan Rema; Zhen Y Liu; Khedoudja Nafa; Laetitia Borsu; Justyna Sadowska; Jacklyn Casanova; Ruben Bacares; Iwona J Kiecka; Anna Razumova; Julie B Son; Lisa Stewart; Tessara Baldi; Kerry A Mullaney; Hikmat Al-Ahmadie; Efsevia Vakiani; Adam A Abeshouse; Alexander V Penson; Philip Jonsson; Niedzica Camacho; Matthew T Chang; Helen H Won; Benjamin E Gross; Ritika Kundra; Zachary J Heins; Hsiao-Wei Chen; Sarah Phillips; Hongxin Zhang; Jiaojiao Wang; Angelica Ochoa; Jonathan Wills; Michael Eubank; Stacy B Thomas; Stuart M Gardos; Dalicia N Reales; Jesse Galle; Robert Durany; Roy Cambria; Wassim Abida; Andrea Cercek; Darren R Feldman; Mrinal M Gounder; A Ari Hakimi; James J Harding; Gopa Iyer; Yelena Y Janjigian; Emmet J Jordan; Ciara M Kelly; Maeve A Lowery; Luc G T Morris; Antonio M Omuro; Nitya Raj; Pedram Razavi; Alexander N Shoushtari; Neerav Shukla; Tara E Soumerai; Anna M Varghese; Rona Yaeger; Jonathan Coleman; Bernard Bochner; Gregory J Riely; Leonard B Saltz; Howard I Scher; Paul J Sabbatini; Mark E Robson; David S Klimstra; Barry S Taylor; Jose Baselga; Nikolaus Schultz; David M Hyman; Maria E Arcila; David B Solit; Marc Ladanyi; Michael F Berger
Journal:  Nat Med       Date:  2017-05-08       Impact factor: 53.440

8.  Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study.

Authors:  Jason K Sicklick; Shumei Kato; Ryosuke Okamura; Maria Schwaederle; Michael E Hahn; Casey B Williams; Pradip De; Amy Krie; David E Piccioni; Vincent A Miller; Jeffrey S Ross; Adam Benson; Jennifer Webster; Philip J Stephens; J Jack Lee; Paul T Fanta; Scott M Lippman; Brian Leyland-Jones; Razelle Kurzrock
Journal:  Nat Med       Date:  2019-04-22       Impact factor: 53.440
  8 in total
  2 in total

Review 1.  Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in Dogs.

Authors:  Jason Chibuk; Andi Flory; Kristina M Kruglyak; Nicole Leibman; Alexis Nahama; Nilesh Dharajiya; Dirk van den Boom; Taylor J Jensen; Jeffrey S Friedman; M Richard Shen; Francisco Clemente-Vicario; Ilya Chorny; John A Tynan; Katherine M Lytle; Lauren E Holtvoigt; Muhammed Murtaza; Luis A Diaz; Dana W Y Tsui; Daniel S Grosu
Journal:  Front Vet Sci       Date:  2021-03-23

2.  The Potential of a Digital Twin in Surgery.

Authors:  Hanad Ahmed; Laurence Devoto
Journal:  Surg Innov       Date:  2020-12-08       Impact factor: 2.058
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.